Showing results (1391-1400 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|August 16, 2013
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoproteinJorge Carrillo, Clara Restrepo, Norma I Rallón, et al.AIDS (London, England)|August 16, 2013
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cureKristine B Patterson, Heather A Prince, Trenton Stevens, et al.AIDS (London, England)|August 16, 2013
Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approachRoksana Karim, Wendy J Mack, Tracey Stiller, et al.AIDS (London, England)|August 8, 2013
Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 diseaseSilvia Ghezzi, Laura Galli, Anna Kajaste-Rudnitski, et al.AIDS (London, England)|August 8, 2013
HLA B*5701 status, disease progression, and response to antiretroviral therapyAIDS (London, England)|August 9, 2013
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patientsZheng Zhang, Junliang Fu, Xiangsheng Xu, et al.AIDS (London, England)|August 9, 2013
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis, Bryan E Shepherd, Cathy A Jenkins, et al.AIDS (London, England)|July 1, 1990
HIV and infant feeding practices: epidemiological implications for sub-Saharan African countriesA Nicoll, J Z Killewo, C MgoneAIDS (London, England)|July 1, 1990
Seronegative disseminated coccidioidomycosis in patients with HIV infectionD Antoniskis, R A Larsen, B Akil, et al.AIDS (London, England)|January 1, 1990
HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluationG Landonio, M Galli, A Nosari, et al.Pageof 1,045